Biofrontera (BFRI) EBT Margin (2020 - 2025)

Biofrontera's (BFRI) quarterly EBT Margin came in at 32.98% in Q4 2025, up 4412.0% year-on-year from 0.73% in Q4 2024, and up 134.7% quarter-over-quarter from 95.06% in Q3 2025.

Biofrontera (BFRI) EBT Margin (2020 - 2025) Analysis & Trends

Biofrontera's EBT Margin history runs 6 years deep, the most recent figure standing at 32.98% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 4412.0% year-over-year to 32.98% in Q4 2025; TTM through Dec 2025 was 25.2%, a 2233.0% increase from a year earlier, with the FY2025 full-year figure at 25.2%, up 2232.0% from the prior year.
  • EBT Margin advanced to 32.98% in Q4 2025 per BFRI's latest filing, from 95.06% in the prior quarter.
  • Across five years, EBT Margin topped out at 97.48% in Q4 2021 and bottomed at 369.31% in Q3 2021.
  • The 5-year median for EBT Margin is 59.04% (2022), against an average of 56.35%.
  • Across the five-year window, EBT Margin plunged 27940 bps in 2021 and surged 30996 bps in 2022, its largest moves.
  • Year by year, EBT Margin stood at 97.48% in 2021, then tumbled by 128 bps to 27.44% in 2022, then jumped by 221 bps to 33.22% in 2023, then tumbled by 134 bps to 11.14% in 2024, then soared by 396 bps to 32.98% in 2025.
  • Per Business Quant, the three latest BFRI EBT Margin figures stand at 32.98% (Q4 2025), 95.06% (Q3 2025), and 58.73% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Biofrontera 12.70 Mn 6.29 Mn 14.09 Mn 32.98%

Historic Data

Download Data
DateValue
Dec 31, 2025 32.98%
Sep 30, 2025 -95.06%
Jun 30, 2025 -58.73%
Mar 31, 2025 -48.95%
Dec 31, 2024 -11.14%
Sep 30, 2024 -62.87%
Jun 30, 2024 -3.02%
Mar 31, 2024 -131.90%
Dec 31, 2023 33.22%
Sep 30, 2023 -71.28%
Jun 30, 2023 -167.97%
Mar 31, 2023 -85.57%
Dec 31, 2022 -27.44%
Sep 30, 2022 -59.35%
Jun 30, 2022 -19.07%
Mar 31, 2022 57.34%
Dec 31, 2021 97.48%
Sep 30, 2021 -369.31%
Jun 30, 2021 -61.78%
Mar 31, 2021 -74.47%